Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Fund moves › Insulet Corporation › Capital Research Global Investors cut its PODD stake below 5% (2.4%) Fund moves
Why it stands out The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Date of the event that required the filing Mar 31, 2026
Reporting period Not applicable
Filed with the SEC May 14, 2026 passive 5% holder
Context Change vs prior quarter Undefined
Compared with the manager's prior 13F
Tracked managers with the same change NaN
For the same quarter
0001422848-26-000059
Data quality Verified: identifiers matched exactly
Around the same time Insider selling
Traded Jun 3 · filed 1 day later Not reported under a pre-arranged trading plan
An Insulet director sold $60K of Insulet shares. The filing does not indicate a pre-arranged trading plan.
Insider buying
Traded Jun 3 · filed 1 day later
An Insulet director paid $400K out of pocket for Insulet shares. 1 other person at Insulet bought some too, in the same month. It was the first purchase in 6 months.
Insider buying
Their first buy on record Traded Jun 3 · filed the same day
An Insulet director paid $497K out of pocket for Insulet shares. 1 other person at Insulet bought some too, in the same month. Shares held went up 50% with this purchase.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Dec 15, 2025 Company filing · Form 8-K · Auditor change Changed its auditor “On December 15, 2025, the Audit Committee of the Board of Directors of the Company notified GT, the Company’s then independent registered public accounting firm, that the Audit Committee selected PwC as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026.” Jan 29, 2026 Company filing · Form 8-K · Material agreement Signed an important agreement Feb 5, 2026 5% stake FMR LLC reported a passive stake (13G) of 9.0% Feb 18, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors Feb 20, 2026 Insider · 7 days before an 8-K CEO purchased ~$1.03M of PODD shares in the open market Feb 25, 2026 Insider · 2 days before an 8-K Director purchased ~$500K of PODD shares in the open market Feb 27, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On February 27, 2026, Insulet Corporation (the “Company”) entered into a severance agreement and release (the “Severance Agreement”) with Ana M. Chadwick, the Company’s former Chief Financial Officer.” Mar 12, 2026 FDA Recall: Omnipod 5 Pods. Model/Catalog number: PT-001662 ASM 5PK Pod STRL OPS G6G7 Mar 27, 2026 5% stake The Vanguard Group reported a passive stake (13G) What came next Apr 29, 2026 Congress Disclosed partial sale of PODD — reported range $100,001 - $250,000 Apr 30, 2026 5% stake Vanguard Capital Management reported a passive stake (13G) of 7.5% May 6, 2026 Company filing · Form 8-K · Results Reported its results May 6, 2026 5% stake FMR LLC reported a passive stake (13G) of 5.6%